Showing 111-120 of 10577 results for "".
SHTG: Defining the Unmet Clinical Need
https://reachmd.com/programs/cme/shtg-defining-the-unmet-clinical-need/33224/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
https://reachmd.com/programs/cme/setting-the-bar-guideline-recommended-treatment-in-hypertriglyceridemia/33221/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.SHTG: Decoding the Latest Clinical Trial Outcomes
https://reachmd.com/programs/cme/shtg-decoding-the-latest-clinical-trial-outcomes/33225/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.APOC3 Inhibition: A Novel Approach to Lowering TGs
https://reachmd.com/programs/cme/apoc3-inhibition-a-novel-approach-to-lowering-tgs/33222/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.COVID-19 & Site Selection: Preventing the Spread of Infection from Patient to Practitioner
https://reachmd.com/programs/covid-19-frontlines/covid-19-site-selection-preventing-the-spread-of-infection-from-patient-to-practitioner/11381/As the COVID-19 pandemic continues to evolve, this nurse practitioner’s research can help his colleagues avoid contamination.Seltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
https://reachmd.com/clinical-practice/psychiatry-and-mental-health/seltorexant-vs-quetiapine-xr-in-mdd-with-insomnia-a-26-week-phase-3-comparison/37644/Compare efficacy, safety, and tolerability of adjunctive seltorexant versus quetiapine XR in MDD patients with insomnia symptoms.With or Without Surgical Backup? Settling the Debate on PCI
https://reachmd.com/programs/heart-matters/with-or-without-surgical-backup-settling-the-debate-on-pci/4193/The performance of percutaneous coronary intervention (PCI) without a surgical backup has long produced controversy. In recent years, off-site PCI has become more common, and clinical evidence demonstrates comparable outcomes for on-site and off-site procedures. How does this shift allow us to serveWashington's Push For Evidence-Based Medicine
https://reachmd.com/programs/clinicians-roundtable/washingtons-push-for-evidence-based-medicine/4373/Evidence-based medicine has been gaining momentum among the medical community, but there are things happening in our nation's capital that could impact this coming trend. Dr. Les Paul, vice president of clinical and scientific affairs for the National Pharmaceutical Council, tells host Bruce JapsenComparative Effectiveness and the Economic Stimulus Package
https://reachmd.com/programs/clinicians-roundtable/comparative-effectiveness-and-the-economic-stimulus-package/4372/Comparative effectiveness is gaining momentum as a way to decide what drugs and devices should be used by doctors. But why was it part of the economic stimulus approved by Congress and pushed by President Obama? Dr. Les Paul, vice president of clinical and scientific affairs at the National PharmaceThe Bone Setter of Ghana
https://reachmd.com/programs/focus-on-global-medicine/the-bone-setter-of-ghana/2712/What happens to someone who breaks their hip when there is no orthopedic surgeon to provide care? In many third-world countries, where medical caregivers are few and far between, how do people find treatment for their medical problems? Traditional healers may be part of the answer. So what can we le